CLS003 / Maruho - LARVOL DELTA

Retrospective Study of the Safety and Efficacy of Patients With RVO in Subjects Who Completed Parent Study CLS1003-201 (clinicaltrials.gov) - P=N/A; N=30; Recruiting; Sponsor: Clearside Biomedical, Inc.; Not yet recruiting ➔ Recruiting

Enrollment open • Biosimilar • Diabetic Macular Edema • Ophthalmology • Retinal Vein Occlusion • Venous Thromboembolism

Topical Ionic Contra-Viral Therapy in Actinic Keratosis (clinicaltrials.gov) - P2; N=32; Recruiting; Sponsor: Cutanea Life Sciences, Inc.; Trial primary completion date: Apr 2019 ➔ Sep 2019

Clinical • Trial primary completion date

ICVT in HPV-induced Genital Lesions of Immunocompromised and Immunocompetent Patients (clinicaltrials.gov) - P2; N=28; Terminated; Sponsor: Cutanea Life Sciences, Inc.; N=48 ➔ 28; Trial completion date: Mar 2019 ➔ Oct 2018; Recruiting ➔ Terminated; Trial primary completion date: Mar 2019 ➔ Oct 2018; Lack of effect in interim analysis

Clinical • Enrollment change • Trial completion date • Trial primary completion date • Trial termination